These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16363564)

  • 21. Helicobacter pylori: microbiology and interactions with gastrointestinal microflora.
    Dzierzanowska-Fangrat K; Dzierzanowska D
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():5-14. PubMed ID: 17033102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions.
    Fuccio L; Eusebi LH; Bazzoli F
    Am J Gastroenterol; 2010 Jul; 105(7):1674-5; author reply 1675. PubMed ID: 20606668
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.
    Rozynek E; Dzierzanowska-Fangrat K; Celińska-Cedro D; Jóźwiak P; Madaliński K; Dzierzanowska D
    Acta Microbiol Pol; 2002; 51(3):255-63. PubMed ID: 12588100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotic resistance of Helicobacter pylori].
    Wang F; Shen SR; Zhou JD; Xu CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):447-50. PubMed ID: 17611323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori.
    Mégraud F
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S49-54. PubMed ID: 8574736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].
    MMW Fortschr Med; 2005 May; 147(20):52. PubMed ID: 15957863
    [No Abstract]   [Full Text] [Related]  

  • 27. [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
    Mitsuno Y; Yoshida H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():452-4. PubMed ID: 11979826
    [No Abstract]   [Full Text] [Related]  

  • 28. [Characteristics of anti-microbial agents and its clinical choice for H. pylori treatment].
    Aoyama N; Shirasaka D; Sakai T; Shirakawa K
    Nihon Rinsho; 1999 Jan; 57(1):43-52. PubMed ID: 10036934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clarithromycin (CAM)].
    Murakami K; Nasu M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():667-70. PubMed ID: 11979867
    [No Abstract]   [Full Text] [Related]  

  • 30. Resistance of Helicobacter pylori to antibiotics and its impact on treatment options.
    Mégraud F
    Drug Resist Updat; 2001 Jun; 4(3):178-86. PubMed ID: 11768331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The cause of failure of eradication treatment of Helicobacter pylori].
    Chen G; Takeuchi Y; Kikuchi R; Arai D; Fukuchi K; Gomi K
    Rinsho Byori; 2005 Aug; 53(8):692-7. PubMed ID: 16190353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):77-82. PubMed ID: 18641590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany.
    Wüppenhorst N; Lenze F; Ross M; Kist M
    J Antimicrob Chemother; 2011 Jan; 66(1):222-3. PubMed ID: 21051371
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of Lansap combination therapy for eradication of H. pylori.
    Nagahara A; Miwa H; Hojo M; Yoshizawa T; Kawabe M; Osada T; Kurosawa A; Ohkusa T; Watanabe S
    Helicobacter; 2007 Dec; 12(6):643-4. PubMed ID: 18001408
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study.
    Dzierzanowska-Fangrat K; Rozynek E; Celińska-Cedro D; Jarosz M; Pawłowska J; Szadkowski A; Budzyńska A; Nowak J; Romańczuk W; Prosiecki R; Jóźwiak P; Dzierzanowska D
    Int J Antimicrob Agents; 2005 Sep; 26(3):230-4. PubMed ID: 16122912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Helicobacter pylori.
    Bytzer P; O'Morain C
    Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs].
    Lochmannová J
    Klin Mikrobiol Infekc Lek; 2010 Dec; 16(6):199-202. PubMed ID: 21243598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary clarithromycin resistance to Helicobacter pylori and therapy failure in children: the experience in West Virginia.
    Elitsur Y; Lawrence Z; Rüssmann H; Koletzko S
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):327-8. PubMed ID: 16540805
    [No Abstract]   [Full Text] [Related]  

  • 39. Helicobacter pylori eradication and its effect on iron stores: a reappraisal.
    Cardenas VM; Ortiz M; Graham DY
    J Infect Dis; 2006 Sep; 194(5):714; author reply 715-6. PubMed ID: 16897673
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].
    Díte P; Kunovská M; Pulgretová D; Woznica V; Petrtýl J; Hůlek P; Pásková J; Dostalík Z; Novotný I; Procházka V; Hegyi P; Zelenková J; Samek M; Králová Z; Vyhnálek P; Matejovic F; Weinberg J; Kyzeková J
    Vnitr Lek; 2002 Oct; 48(10):976-80. PubMed ID: 16737149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.